Dr. Wu Xiaohua (吴小华) - Director of Gynecologic Oncology at Fudan University Shanghai Cancer Center

Introduction

Dr. Wu Xiaohua (吴小华) is the Director of the Department of Gynecologic Oncology at Fudan University Shanghai Cancer Center (FUSCC), and one of China's most distinguished and nationally recognized gynecologic oncologists. With over 25 years of specialized experience, Dr. Wu is a leading authority in the surgical and multimodal treatment of gynecologic cancers, with particular expertise in radical surgery for cervical cancer, ovarian cancer cytoreduction, and complex pelvic reconstructive surgery. She is one of China's foremost experts in pelvic exenteration and ultra-radical gynecologic surgery for locally advanced and recurrent gynecologic malignancies — procedures requiring exceptional surgical skill and multidisciplinary coordination. Her commitment to oncologic excellence, surgical innovation, and compassionate patient care has made FUSCC's Department of Gynecologic Oncology one of the premier gynecologic cancer centers in Asia, and a trusted destination for international patients seeking expert gynecologic cancer care in Shanghai.

Academic Distinctions & Leadership

• Director, Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center (FUSCC)
• Professor of Gynecologic Oncology, Fudan University Shanghai Medical College
• Chief Physician, Fudan University Shanghai Cancer Center
• Chairman, Gynecologic Oncology Committee, Chinese Anti-Cancer Association
• Vice Chairman, Gynecologic Oncology Branch, Chinese Medical Association
• Member, International Gynecologic Cancer Society (IGCS)
• Member, Society of Gynecologic Oncology (SGO)
• Member, European Society of Gynaecological Oncology (ESGO)
• Member, Asia Pacific Gynecologic Oncology Trials Group (APGOT)
• Editorial Board Member, multiple leading gynecologic oncology journals (Chinese and international)
• Recipient, National Science and Technology Progress Award
• Recipient, Shanghai Science and Technology Award (multiple times)
• Recipient, Chinese Medical Science and Technology Award
• Recipient, Wu Jieping Medical Innovation Award

Specializations & Expertise

Cervical Cancer Surgery

• Radical hysterectomy (Querleu-Morrow type B, C, D) for cervical cancer
• Laparoscopic and robotic radical hysterectomy
• Nerve-sparing radical hysterectomy for bladder function preservation
• Fertility-sparing radical trachelectomy (abdominal and vaginal)
• Pelvic lymph node dissection and para-aortic lymph node dissection
• Sentinel lymph node mapping and biopsy
• Surgery after neoadjuvant chemotherapy or chemoradiation
• Pelvic exenteration (anterior, posterior, total) for recurrent or locally advanced cervical cancer
• Urinary diversion and pelvic reconstruction after exenteration

Ovarian Cancer Surgery

• Primary cytoreductive surgery (debulking) for advanced ovarian cancer — including bowel resection, diaphragm stripping, splenectomy, and peritoneal stripping
• Interval debulking surgery after neoadjuvant chemotherapy
• Secondary cytoreductive surgery for recurrent ovarian cancer
• Fertility-sparing surgery for early-stage ovarian cancer
• Laparoscopic staging surgery for early ovarian cancer
• Surgery for borderline ovarian tumors
• HIPEC (hyperthermic intraperitoneal chemotherapy) coordination for ovarian cancer

Endometrial Cancer Surgery

• Laparoscopic and robotic hysterectomy with comprehensive surgical staging
• Sentinel lymph node mapping and biopsy
• Extended surgery for high-risk and advanced endometrial cancer
• Fertility-sparing management for early endometrial cancer
• Surgery for uterine sarcoma

Pelvic Exenteration & Ultra-Radical Surgery

• Total pelvic exenteration for recurrent cervical, endometrial, and vaginal cancer
• Anterior pelvic exenteration
• Posterior pelvic exenteration
• Pelvic reconstruction after exenteration (neovagina, urinary diversion, bowel reconstruction)
• Laterally extended endopelvic resection (LEER) for sidewall disease
• Intraoperative radiation therapy (IORT) coordination

Vulvar & Vaginal Cancer Surgery

• Radical vulvectomy and modified radical vulvectomy
• Inguinofemoral lymphadenectomy (open and minimally invasive)
• Sentinel lymph node biopsy for vulvar cancer
• Vaginal cancer surgery
• Reconstructive surgery after vulvar cancer resection

Minimally Invasive Gynecologic Oncology

• Laparoscopic radical hysterectomy for cervical cancer
• Robotic-assisted gynecologic oncology surgery
• Laparoscopic comprehensive staging for endometrial and ovarian cancer
• Laparoscopic management of adnexal masses
• Minimally invasive para-aortic lymph node dissection

Multidisciplinary Oncology

• Neoadjuvant chemotherapy for advanced ovarian and cervical cancer
• Adjuvant chemotherapy and targeted therapy coordination
• PARP inhibitor therapy for BRCA-mutated ovarian cancer
• Immunotherapy (pembrolizumab, nivolumab) for gynecologic cancers
• Chemoradiation coordination for cervical and endometrial cancer
• Genetic counseling referral for BRCA and Lynch syndrome
• Palliative care integration for advanced and recurrent disease

Clinical Excellence & Innovation

Dr. Wu has performed thousands of gynecologic oncology surgeries throughout her distinguished career at FUSCC, China's leading comprehensive cancer center. Her department manages one of the largest volumes of gynecologic cancer cases in China, with outcomes that consistently meet or exceed international benchmarks.

Dr. Wu is particularly renowned for her expertise in the most complex and technically demanding gynecologic oncology procedures:

• Pelvic Exenteration Expertise: One of China's most experienced surgeons in pelvic exenteration for recurrent and locally advanced gynecologic cancers. This ultra-radical procedure — involving removal of multiple pelvic organs and complex reconstruction — requires exceptional surgical skill, multidisciplinary coordination, and extensive experience. Dr. Wu's program is one of the most active in China
• Radical Cytoreductive Surgery: Extensive experience in complex debulking surgery for advanced ovarian cancer, including upper abdominal procedures (diaphragm stripping, splenectomy, liver resection) to achieve optimal cytoreduction and improve survival
• Nerve-Sparing Radical Hysterectomy: Pioneered nerve-sparing techniques for radical hysterectomy that preserve bladder, bowel, and sexual function after surgery for cervical cancer, significantly improving quality of life
• Fertility-Sparing Surgery: Specialized expertise in radical trachelectomy and other fertility-preserving approaches for young patients with early-stage cervical and ovarian cancers
• Minimally Invasive Oncologic Surgery: Extensive experience in laparoscopic and robotic radical hysterectomy, comprehensive staging, and complex adnexal surgery
• Precision Oncology Integration: Integrates molecular profiling, BRCA testing, and biomarker-driven therapy selection (PARP inhibitors, immunotherapy) into individualized treatment plans

Research & Academic Contributions

Dr. Wu is a prolific researcher with over 300 peer-reviewed publications in leading Chinese and international gynecologic oncology journals. Her research focuses on:

• Radical surgery for cervical cancer — techniques, outcomes, and quality of life
• Nerve-sparing radical hysterectomy and functional outcomes
• Cytoreductive surgery for advanced ovarian cancer
• Pelvic exenteration outcomes and reconstruction
• Fertility-sparing surgery for gynecologic cancers
• PARP inhibitors and immunotherapy for gynecologic cancers
• Sentinel lymph node techniques in gynecologic oncology
• Hereditary gynecologic cancer syndromes (BRCA, Lynch)

She has been the principal investigator on multiple National Key R&D Programs and National Natural Science Foundation grants, and has led several landmark clinical trials in gynecologic oncology. Dr. Wu regularly presents at major international conferences including the IGCS Annual Meeting, the SGO Annual Meeting, and the ESGO Congress, and is frequently invited as a keynote speaker and live surgery demonstrator.

Training & Education

As a professor at Fudan University Shanghai Medical College and Chairman of the Gynecologic Oncology Committee of the Chinese Anti-Cancer Association, Dr. Wu is deeply committed to advancing gynecologic oncology education and training in China. She supervises doctoral and master's degree students and directs one of China's premier gynecologic oncology fellowship programs at FUSCC.

Her trainees receive comprehensive training in the full spectrum of gynecologic oncology surgery, including radical hysterectomy, cytoreductive surgery, pelvic exenteration, and minimally invasive techniques. Many of her trainees now lead gynecologic oncology programs at major hospitals throughout China.

Hospital Affiliation

Fudan University Shanghai Cancer Center (FUSCC)
270 Dongan Road, Xuhui District, Shanghai 200032

FUSCC is China's leading comprehensive cancer center and one of the largest cancer hospitals in Asia. The Department of Gynecologic Oncology is one of the largest and most specialized in China, featuring:

• Dedicated gynecologic oncology operating rooms with advanced laparoscopic and robotic systems (da Vinci Xi)
• Specialized gynecologic oncology ICU and ward
• Comprehensive pre-operative evaluation and staging facilities
• Advanced imaging (MRI, CT, PET-CT, ultrasound)
• Multidisciplinary gynecologic oncology tumor board with weekly case conferences
• Dedicated ovarian cancer, cervical cancer, endometrial cancer, and vulvar cancer clinics
• On-site HIPEC suite for intraperitoneal chemotherapy
• Intraoperative radiation therapy (IORT) capability
• Genetic counseling and hereditary cancer risk assessment program
• Fertility preservation consultation and coordination
• Radiation oncology and medical oncology fully integrated on-site
• Psycho-oncology and palliative care services
• International patient services with English-speaking coordinators

Patient Care Philosophy

• Patient-Centered Care: Every treatment plan is individualized based on cancer type, stage, molecular profile, fertility goals, functional priorities, and personal circumstances
• Oncologic Radicality: Committed to achieving the most complete cancer resection possible, including ultra-radical surgery when necessary, to maximize survival
• Function Preservation: Nerve-sparing techniques and minimally invasive approaches used to preserve bladder, bowel, and sexual function whenever oncologically safe
• Fertility Preservation: Dedicated to offering fertility-sparing options to young patients whenever oncologically appropriate
• Multidisciplinary Collaboration: All complex cases reviewed by a dedicated gynecologic oncology tumor board integrating surgery, medical oncology, radiation oncology, and radiology
• Precision Oncology: Molecular profiling, BRCA testing, and biomarker-driven therapy selection for every patient
• Transparent Communication: Clear, compassionate communication about diagnosis, prognosis, treatment options, and realistic expectations
• Comprehensive Support: Addresses medical, psychological, nutritional, and social needs throughout the cancer journey

Why Choose Dr. Wu Xiaohua?

• China's Gynecologic Oncology Leader: Director of FUSCC's Department of Gynecologic Oncology and Chairman of the Gynecologic Oncology Committee of the Chinese Anti-Cancer Association — the highest national leadership in the field
• Pelvic Exenteration Authority: One of China's most experienced surgeons in ultra-radical pelvic surgery for recurrent and locally advanced gynecologic cancers
• Radical Cytoreductive Surgery: Extensive experience in complex debulking for advanced ovarian cancer including upper abdominal procedures
• Nerve-Sparing Innovation: Pioneer in nerve-sparing radical hysterectomy for improved quality of life after cervical cancer surgery
• Fertility-Sparing Expertise: Specialized in radical trachelectomy and other fertility-preserving approaches for young patients
• China's Leading Cancer Center: FUSCC is China's top comprehensive cancer hospital with unmatched gynecologic oncology resources
• Cost-Effective Excellence: Gynecologic cancer surgery costs in Shanghai are typically 60-75% lower than in the US or Europe
• Proven International Track Record: International patients from multiple countries have received successful treatment at FUSCC

Conditions Treated

Cervical Cancer

• Squamous cell carcinoma of the cervix — all stages
• Adenocarcinoma of the cervix
• Locally advanced cervical cancer
• Recurrent cervical cancer (including pelvic exenteration candidates)
• High-grade cervical intraepithelial neoplasia (CIN 3)

Ovarian Cancer

• Epithelial ovarian cancer (serous, mucinous, endometrioid, clear cell) — all stages
• Borderline ovarian tumors
• Ovarian germ cell tumors
• Ovarian sex cord-stromal tumors
• Fallopian tube carcinoma
• Primary peritoneal carcinoma
• BRCA-associated hereditary ovarian cancer
• Recurrent ovarian cancer

Endometrial Cancer

• Endometrioid endometrial carcinoma — all stages
• Uterine serous carcinoma
• Clear cell endometrial carcinoma
• Carcinosarcoma (malignant mixed Müllerian tumor)
• Uterine leiomyosarcoma
• Endometrial stromal sarcoma
• Lynch syndrome-associated endometrial cancer

Vulvar & Vaginal Cancer

• Vulvar squamous cell carcinoma
• Vulvar melanoma
• Vaginal carcinoma
• Recurrent vulvar and vaginal cancer

Other Gynecologic Conditions

• Gestational trophoblastic neoplasia (GTN)
• Peritoneal carcinomatosis (gynecologic origin)
• Complex adnexal masses
• Hereditary gynecologic cancer syndromes (BRCA, Lynch)

International Patient Services

China Medical Concierge - Shanghai (CMCS) provides comprehensive support for international patients seeking gynecologic oncology care with Dr. Wu Xiaohua at Fudan University Shanghai Cancer Center.

Pre-Treatment Support

• Medical Record Review: Our team works with FUSCC to review your pathology, imaging, and lab results to assess diagnosis, staging, and treatment options
• Virtual Consultation: Arrange a video consultation with Dr. Wu's team to discuss your case and treatment plan
• Staging Workup Coordination: Comprehensive pre-operative staging including MRI, CT, PET-CT, and tumor markers
• Tumor Board Presentation: Your case can be presented at FUSCC's multidisciplinary gynecologic oncology tumor board
• Genetic Testing Coordination: BRCA and Lynch syndrome testing and counseling if indicated
• Second Opinion: Expert second opinion on diagnosis, staging, and optimal treatment strategy
• Cost Transparency: Detailed cost estimate including evaluation, surgery, chemotherapy, and follow-up
• Visa Assistance: Guidance on obtaining medical visa and invitation letters
• Accommodation: Help finding suitable housing near FUSCC for patient and family

During Treatment

• Professional Medical Interpretation: Experienced interpreters for all medical interactions
• Hospital Admission Support: Assistance with registration, payment, and navigation
• Family Support: Accommodation and support for accompanying family members
• Surgical Coordination: Communication with family during surgery (complex surgeries such as exenteration can be lengthy)
• ICU & Ward Support: Daily updates and interpretation during hospital stay
• Post-operative Care: Comprehensive support during recovery
• Medication Management: Assistance with post-operative medications and pain management
• 24/7 Emergency Support: Round-the-clock assistance throughout your stay

Post-Treatment Care

• Discharge Planning: Coordination of post-discharge care and monitoring
• Medical Report Translation: Complete translation of surgical reports, pathology, and discharge summaries
• Adjuvant Therapy Coordination: Assistance with arranging adjuvant chemotherapy, targeted therapy, immunotherapy, or radiation if recommended
• Follow-up Coordination: Arrange post-operative clinic visits and imaging surveillance
• Long-term Monitoring Plan: Clear guidance on ongoing surveillance schedule
• Complication Management: Support for any post-operative complications
• Telemedicine Follow-up: Virtual consultations for ongoing care after returning home
• Coordination with Home Physicians: Communication with your local gynecologic oncologist or oncologist
• Lifelong Support: Ongoing assistance throughout your cancer journey

Schedule Your Consultation

If you or a loved one has been diagnosed with cervical cancer, ovarian cancer, endometrial cancer, vulvar cancer, or another gynecologic malignancy — including recurrent or locally advanced disease — Dr. Wu Xiaohua at Fudan University Shanghai Cancer Center offers world-class gynecologic oncology expertise at China's leading cancer hospital, at a fraction of Western costs.

Contact China Medical Concierge - Shanghai today to:

• Request a medical record review to assess diagnosis and treatment options
• Schedule a virtual consultation with Dr. Wu's gynecologic oncology team
• Have your case presented at FUSCC's multidisciplinary gynecologic oncology tumor board
• Receive a detailed treatment plan and cost estimate
• Start your journey toward expert gynecologic cancer care in Shanghai

Bridging international patients with China's finest gynecologic oncologists — because when it comes to gynecologic cancer, you deserve the most experienced hands at China's leading cancer center.